{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T18:22:41Z","timestamp":1772821361182,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T00:00:00Z","timestamp":1696377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T00:00:00Z","timestamp":1696377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Bristol Myers Squibb and Janssen Global Services, LLC."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiol Ther"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s40119-023-00332-7","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T02:01:33Z","timestamp":1696384893000},"page":"675-687","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Antiplatelet Treatment Patterns and Outcomes for Secondary Stroke Prevention in the United Kingdom"],"prefix":"10.1007","volume":"12","author":[{"given":"Xuejun","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danshi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay","family":"Horrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Tamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Kahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vignesh","family":"Hariharan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankur","family":"Avinav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,4]]},"reference":[{"key":"332_CR1","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","volume":"20","author":"GBD Stroke Collaborators","year":"2021","unstructured":"GBD Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20:795\u2013820.","journal-title":"Lancet Neurol"},{"key":"332_CR2","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1055\/s-0038-1649503","volume":"38","author":"M Katan","year":"2018","unstructured":"Katan M, Luft A. Global burden of stroke. Semin Neurol. 2018;38:208\u201311.","journal-title":"Semin Neurol"},{"key":"332_CR3","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1161\/STROKEAHA.120.029606","volume":"51","author":"HA Wafa","year":"2020","unstructured":"Wafa HA, Wolfe CDA, Emmett E, Roth GA, Johnson CO, Wang Y. Burden of stroke in Europe: thirty-year projections of incidence, prevalence, deaths, and disability-adjusted life years. Stroke. 2020;51:2418\u201327.","journal-title":"Stroke"},{"key":"332_CR4","unstructured":"Stroke Association. Stroke statistics. 2021. https:\/\/www.stroke.org.uk\/what-is-stroke\/stroke-statistics. Accessed 22 Sep 2021."},{"key":"332_CR5","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/ageing\/afz162","volume":"49","author":"A Patel","year":"2020","unstructured":"Patel A, Berdunov V, Quayyum Z, King D, Knapp M, Wittenberg R. Estimated societal costs of stroke in the UK based on a discrete event simulation. Age Ageing. 2020;49:270\u20136.","journal-title":"Age Ageing"},{"key":"332_CR6","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/S1474-4422(07)70274-0","volume":"6","author":"MF Giles","year":"2007","unstructured":"Giles MF, Rothwell PM. Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol. 2007;6:1063\u201372.","journal-title":"Lancet Neurol"},{"key":"332_CR7","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1056\/NEJMoa1412981","volume":"374","author":"P Amarenco","year":"2016","unstructured":"Amarenco P, Lavallee PC, Labreuche J, et al. One-year risk of stroke after transient ischemic attack or minor stroke. N Engl J Med. 2016;374:1533\u201342.","journal-title":"N Engl J Med"},{"key":"332_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12883-018-1225-y","volume":"19","author":"F Ildstad","year":"2019","unstructured":"Ildstad F, Ellekj\u00e6r H, Wethal T, et al. Stroke risk after transient ischemic attack in a Norwegian prospective cohort. BMC Neurol. 2019;19:2.","journal-title":"BMC Neurol"},{"key":"332_CR9","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1001\/archinte.167.22.2417","volume":"167","author":"CM Wu","year":"2007","unstructured":"Wu CM, McLaughlin K, Lorenzetti DL, Hill MD, Manns BJ, Ghali WA. Early risk of stroke after transient ischemic attack: a systematic review and meta-analysis. Arch Intern Med. 2007;167:2417\u201322.","journal-title":"Arch Intern Med"},{"key":"332_CR10","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1001\/jama.284.22.2901","volume":"284","author":"SC Johnston","year":"2000","unstructured":"Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA. 2000;284:2901\u20136.","journal-title":"JAMA"},{"key":"332_CR11","unstructured":"National Institute for Health and Care Excellence. Stroke and transient ischaemic attack in over 16s: diagnosis and initial management. 2021. https:\/\/www.nice.org.uk\/guidance\/ng128\/resources\/stroke-and-transient-ischaemic-attack-in-over-16s-diagnosis-and-initial-management-pdf-66141665603269. Accessed 22 Feb 2021."},{"key":"332_CR12","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"WJ Powers","year":"2019","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2019;50:e344\u2013418.","journal-title":"Stroke"},{"key":"332_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k5130","volume":"363","author":"K Prasad","year":"2018","unstructured":"Prasad K, Siemieniuk R, Hao Q, et al. Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline. BMJ. 2018;363:k5130.","journal-title":"BMJ"},{"key":"332_CR14","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1177\/1747493018786616","volume":"13","author":"JM Boulanger","year":"2018","unstructured":"Boulanger JM, Lindsay MP, Gubitz G, et al. Canadian stroke best practice recommendations for acute stroke management: prehospital, emergency department, and acute inpatient stroke care, 6th edition, update 2018. Int J Stroke. 2018;13:949\u201384.","journal-title":"Int J Stroke"},{"key":"332_CR15","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa1800410","volume":"379","author":"SC Johnston","year":"2018","unstructured":"Johnston SC, Easton JD, Farrant M, et al. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N Engl J Med. 2018;379:215\u201325.","journal-title":"N Engl J Med"},{"key":"332_CR16","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1001\/jamaneurol.2019.0932","volume":"76","author":"H Tillman","year":"2019","unstructured":"Tillman H, Johnston SC, Farrant M, et al. Risk for major hemorrhages in patients receiving clopidogrel and aspirin compared with aspirin alone after transient ischemic attack or minor ischemic stroke: a secondary analysis of the POINT randomized clinical trial. JAMA Neurol. 2019;76:774\u201382.","journal-title":"JAMA Neurol"},{"key":"332_CR17","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.amjcard.2021.05.028","volume":"153","author":"GA Medranda","year":"2021","unstructured":"Medranda GA, Zhang C, Doros G, et al. Meta-analysis of usefulness of antiplatelet therapy in ischemic Stroke or transient ischemic attack. Am J Cardiol. 2021;153:129\u201334.","journal-title":"Am J Cardiol"},{"key":"332_CR18","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.009856","volume":"7","author":"NF Chi","year":"2018","unstructured":"Chi NF, Wen CP, Liu CH, et al. Comparison between aspirin and clopidogrel in secondary stroke prevention based on real-world data. J Am Heart Assoc. 2018;7:e009856.","journal-title":"J Am Heart Assoc"},{"key":"332_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0221750","volume":"14","author":"AN Vidyanti","year":"2019","unstructured":"Vidyanti AN, Chan L, Lin CL, et al. Aspirin better than clopidogrel on major adverse cardiovascular events reduction after ischemic stroke: a retrospective nationwide cohort study. PLoS ONE. 2019;14: e0221750.","journal-title":"PLoS ONE"},{"key":"332_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0242466","volume":"15","author":"YS Wong","year":"2020","unstructured":"Wong YS, Tsai CF, Hsu YH, Ong CT. Efficacy of aspirin, clopidogrel, and ticlopidine in stroke prevention: a population-based case-cohort study in Taiwan. PLoS ONE. 2020;15:e0242466.","journal-title":"PLoS ONE"},{"key":"332_CR21","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1016\/S0140-6736(15)00195-6","volume":"386","author":"JN Newton","year":"2015","unstructured":"Newton JN, Briggs AD, Murray CJ, et al. Changes in health in England, with analysis by English regions and areas of deprivation, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386:2257\u201374.","journal-title":"Lancet"},{"key":"332_CR22","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1177\/2396987317746516","volume":"3","author":"XM Xu","year":"2018","unstructured":"Xu XM, Vestesson E, Paley L, et al. The economic burden of stroke care in England, Wales and Northern Ireland: using a national stroke register to estimate and report patient-level health economic outcomes in stroke. Eur Stroke J. 2018;3:82\u201391.","journal-title":"Eur Stroke J"},{"key":"332_CR23","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1212\/WNL.0b013e31822f0423","volume":"77","author":"CD Bushnell","year":"2011","unstructured":"Bushnell CD, Olson DM, Zhao X, et al. Secondary preventive medication persistence and adherence 1 year after stroke. Neurology. 2011;77:1182\u201390.","journal-title":"Neurology"},{"key":"332_CR24","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1007\/s00228-012-1293-7","volume":"68","author":"K Ostergaard","year":"2012","unstructured":"Ostergaard K, Hallas J, Bak S, Christensen R, Gaist D. Long-term use of antiplatelet drugs by stroke patients: a follow-up study based on prescription register data. Eur J Clin Pharmacol. 2012;68:1631\u20137.","journal-title":"Eur J Clin Pharmacol"},{"key":"332_CR25","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s40266-016-0365-2","volume":"33","author":"M Wawruch","year":"2016","unstructured":"Wawruch M, Zatko D, Wimmer G Jr, et al. Factors influencing non-persistence with antiplatelet medications in elderly patients after ischaemic stroke. Drugs Aging. 2016;33:365\u201373.","journal-title":"Drugs Aging"},{"key":"332_CR26","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1161\/STROKEAHA.118.023954","volume":"50","author":"DG Hackam","year":"2019","unstructured":"Hackam DG, Spence JD. Antiplatelet therapy in ischemic stroke and transient ischemic attack. Stroke. 2019;50:773\u20138.","journal-title":"Stroke"},{"key":"332_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1215340","volume":"369","author":"Y Wang","year":"2013","unstructured":"Wang Y, Wang Y, Zhao X, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013;369:11\u20139.","journal-title":"N Engl J Med"},{"key":"332_CR28","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1161\/CIRCULATIONAHA.119.040713","volume":"140","author":"SC Johnston","year":"2019","unstructured":"Johnston SC, Elm JJ, Easton JD, et al. Time course for benefit and risk of clopidogrel and aspirin after acute transient ischemic attack and minor ischemic stroke. Circulation. 2019;140:658\u201364.","journal-title":"Circulation"},{"key":"332_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k5108","volume":"363","author":"Q Hao","year":"2018","unstructured":"Hao Q, Tampi M, O\u2019Donnell M, Foroutan F, Siemieniuk RA, Guyatt G. Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis. BMJ. 2018;363: k5108.","journal-title":"BMJ"},{"key":"332_CR30","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s11239-018-1786-z","volume":"47","author":"B Kheiri","year":"2019","unstructured":"Kheiri B, Osman M, Abdalla A, et al. Clopidogrel and aspirin after ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis of randomized clinical trials. J Thromb Thrombolysis. 2019;47:233\u201347.","journal-title":"J Thromb Thrombolysis"},{"key":"332_CR31","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1093\/ehjqcco\/qcz024","volume":"5","author":"F Pugliese","year":"2019","unstructured":"Pugliese F, Arasaratnam P, Moellenberg M, Dani S. Short- vs. long-term dual antiplatelet therapy in secondary prevention for ischaemic stroke: a network metanalysis. Eur Heart J Qual Care Clin Outcomes. 2019;5:298\u2013309.","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"332_CR32","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1056\/NEJMoa1802712","volume":"378","author":"P Amarenco","year":"2018","unstructured":"Amarenco P, Lavallee PC, Monteiro Tavares L, et al. Five-year risk of stroke after TIA or minor ischemic stroke. N Engl J Med. 2018;378:2182\u201390.","journal-title":"N Engl J Med"},{"key":"332_CR33","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1161\/STR.0000000000000158","volume":"49","author":"WJ Powers","year":"2018","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, et al. 2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2018;49:e46\u2013110.","journal-title":"Stroke"}],"container-title":["Cardiology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40119-023-00332-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40119-023-00332-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40119-023-00332-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T11:32:27Z","timestamp":1701948747000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40119-023-00332-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["332"],"URL":"https:\/\/doi.org\/10.1007\/s40119-023-00332-7","relation":{},"ISSN":["2193-8261","2193-6544"],"issn-type":[{"value":"2193-8261","type":"print"},{"value":"2193-6544","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,4]]},"assertion":[{"value":"20 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Xuejun Liu was an employee of Bristol Myers Squibb at the time of the study and is a current PhD candidate of the University of North Carolina at Chapel Hill, School of Public Health. Jenny Jiang, Danshi Li, Jay Horrow, Anja Kahl, and Xiaoyan Li are current employees of Bristol Myers Squibb. Hiroshi Tamada was an employee of Bristol Myers Squibb at the time of the study and is currently employed as the founder of Nassau Biopharma Consulting. Vignesh Hariharan was an employee of Mu Sigma Inc. at the time of the study and is a current employee of Accenture. Ankur Avinav was an employee of Mu Sigma Inc. at the time of the study and is a current employee of Indium Software.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article had been approved by the Independent Scientific Advisory Committee (ISAC), with the reference number ISAC19_240R. Although this study does not involve primary data collection from human participants, it was performed in accordance with the ethical principles set forth in the Helsinki Declaration of 1964 and its later amendments. Given that this study was based on retrospective analyses of secondary databases without enrollment of patients, all data were anonymized and de-identified prior to analysis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}